Trial intelligence / Profile preview

Letrozole versus estradiol-based endometrial preparation in frozen embryo transfer cycles for women with polycystic ovarian syndrome

IRCT20150105020558N3Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Apr 2021
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, single-blind trial of letrozole, estradiol and progesterone in polycystic ovary syndrome (PCOS) and infertility (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Live Birth Rate. Started Apr 2021; status: completed.

02

Drugs

letrozoleestradiolprogesterone
03

Conditions

polycystic ovary syndrome (PCOS)infertility

Beyond the preview

Go deeper on IRCT20150105020558N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20150105020558N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call